Introduction
You used to be able to skip a few meals, add a couple of runs, and the weight would shift. Now you're eating less than you have in years, exercising more than ever, and the scales won't move. Or they're going the wrong way. You're not lazy. You're not broken. Your metabolism is being rewritten by a hormonal shift that most doctors don't have 30 minutes to explain.
If you've ever found yourself at 1am scrolling through a Reddit thread titled "I'm doing everything right and NOTHING works," this article is for you.
We're going to walk through what happens to insulin sensitivity when oestrogen declines, why your body starts storing fat differently, why calorie restriction often backfires in perimenopause, and what the clinical evidence actually supports. No meal plans. No miracle supplements. Just the biology, the evidence, and the context you need to make informed decisions with your healthcare provider.
What oestrogen actually does for your metabolism
Most people think of oestrogen as a reproductive hormone. It is. But it also runs a surprising amount of your metabolic machinery, and nobody tells you this until it starts breaking down.
When oestrogen levels are stable, it helps your cells respond efficiently to insulin (the hormone that moves glucose out of your blood and into your cells for energy). It supports healthy glucose metabolism, promotes fat storage in subcutaneous tissue (hips, thighs, the metabolically safer kind), and helps regulate appetite through signalling pathways in the hypothalamus. In other words, oestrogen has been quietly managing your weight, your energy, and your hunger for decades. You just never had to think about it.
A 2021 review in The American Journal of Pathology confirmed that oestrogen receptors, particularly oestrogen receptor alpha (ERα), are critical for maintaining insulin sensitivity in skeletal muscle, liver, and adipose tissue. When those receptors are disrupted in animal models, the result is significant insulin resistance, even without other changes.
That's the key insight: oestrogen isn't just involved in metabolism. It's load-bearing. When it starts to decline, the system that was working quietly in the background starts to fail, and you feel every part of it.
What happens during perimenopause
Here's something that catches most women off guard: perimenopause can begin in your mid-to-late thirties, and it typically lasts four to ten years. During this time, oestrogen doesn't just drop. It fluctuates wildly. Some months it spikes higher than it ever has. Other months it crashes. If you feel like your body is a different body from month to month, that's because hormonally, it almost is.
This instability is the metabolic disruption, not just the eventual decline. As oestrogen becomes erratic and eventually trends downward, several things happen at once.
Your cells become less responsive to insulin. With less oestrogen supporting insulin signalling, your body needs to produce more insulin to manage the same amount of glucose. This is insulin resistance, and it happens gradually, often without any obvious symptoms beyond stubborn weight changes and fatigue. A 2023 review in Gynecological and Reproductive Endocrinology & Metabolism found that this insulin resistance is compounded by a slow, progressive increase in cortisol that accompanies ageing. A double hit to metabolic efficiency.
Your fat storage pattern shifts. This is the one that makes women stare at the mirror and wonder what happened. Before perimenopause, oestrogen promotes subcutaneous fat storage, the kind that sits under your skin on hips and thighs and is relatively metabolically benign. As oestrogen declines, your body redirects fat towards visceral adipose tissue, the deep abdominal fat that wraps around your organs. You might not have gained much weight overall, but your shape has changed. A 2021 study in Scientific Reports found that changes in subcutaneous fat tissue after menopause were associated with significantly increased visceral fat mass, and that this shift was directly associated with decreased insulin sensitivity. Postmenopausal women carried substantially more visceral fat for the same total body fat compared to premenopausal women.
This isn't about how your jeans fit. Visceral fat is metabolically active. It produces inflammatory compounds that further worsen insulin resistance, creating a feedback loop: less oestrogen leads to more visceral fat, which drives more inflammation, which worsens insulin resistance, which promotes more visceral fat. Round and round.
Your appetite regulation changes. Oestrogen influences neuropeptide signalling in the hypothalamus, the part of your brain that governs hunger and satiety. A 2025 review in PMC described how declining oestrogen alters these pathways, shifting the body from effective appetite control and high insulin sensitivity during premenopause to increased appetite and insulin resistance in postmenopause.
So when you feel hungrier than you used to, even though you're eating the same amount or more, that's not a failure of willpower. That's neurochemistry.
Why calorie restriction often makes things worse
This is the part that frustrates women the most, because it contradicts everything they've been told.
We hear it constantly in community forums: "I'm eating 1,200 calories a day and running three times a week and the scale hasn't moved in two months." The instinct is to eat even less, push even harder. But during perimenopause, aggressive calorie restriction triggers a cascade of hormonal responses that actively work against fat loss.
Cortisol rises. Your body interprets severe restriction as a threat. Cortisol, your primary stress hormone, increases in response. And cortisol specifically promotes visceral fat storage, the exact kind of fat you're trying to shift. It also breaks down muscle tissue for glucose, which further reduces your metabolic rate. So you're eating less, stressing your body more, and storing fat in the worst possible place. That's not a character flaw. That's biochemistry.
Metabolic adaptation kicks in. Your resting metabolic rate drops to conserve energy. Hunger hormones increase. Your body becomes more efficient at extracting and storing energy from less food. This is well-documented metabolic adaptation, and it's more pronounced in women during hormonal transitions.
Muscle loss accelerates. Without adequate protein and resistance training, calorie restriction doesn't just burn fat. It burns lean muscle tissue. And muscle is the most metabolically active tissue in your body. Less muscle means a lower resting metabolic rate, which means even fewer calories burned at rest, which means the deficit you're creating becomes less and less effective. It's a treadmill, and not the kind at the gym.
The evidence supports a moderate approach instead. A 2023 randomised controlled trial found that a modest calorie deficit of 250 to 600 calories per day, combined with concurrent aerobic and resistance training, reduced insulin resistance in premenopausal women without triggering the severe metabolic adaptation seen with aggressive restriction.
The takeaway: eating less is not the same as eating right. In perimenopause, the difference matters more than ever.
What the evidence actually supports
If you've been reading about perimenopause for a while, some of what follows will sound familiar. Resistance training. Protein. Mediterranean diet. You've probably seen these recommendations before and thought, "Yes, I know, but it's not working."
Here's the thing: those recommendations are usually given without the context of why they matter specifically for insulin resistance during a hormonal transition. Knowing the mechanism changes how you approach them, how much you prioritise them, and what you say to your doctor when you ask for help.
The clinical evidence points to four interventions with meaningful support. None of them are quick fixes. All of them address the underlying biology rather than fighting against it.
1. Resistance training
This is the single most evidence-supported intervention for metabolic health in perimenopause and beyond. Not cardio. Not yoga. Picking up heavy things and putting them down again.
If you spent your twenties and thirties being told that the treadmill was the answer to everything, you're not alone. An entire generation of women was steered towards cardio as the default exercise prescription. But for insulin resistance in perimenopause, the evidence points in a different direction.
A 2024 systematic review and meta-analysis of randomised controlled trials found that both low and high volume resistance training improved body adiposity, metabolic risk markers, and inflammation in overweight and obese postmenopausal women. A separate six-year longitudinal study found that resistance training prevented 1.5 kg of body fat gain compared to non-exercisers. That sounds modest on paper, but over six years, it represents a real divergence in metabolic trajectory.
Why it works: resistance training builds and preserves muscle mass, which increases your resting metabolic rate and improves insulin sensitivity directly. It also reduces visceral fat independently of weight loss. Your body composition can improve even if the number on the scales doesn't change. If your GP is only looking at your BMI, this distinction matters.
The evidence suggests twice weekly at minimum, focusing on progressive overload (gradually increasing the challenge over time). You don't need to become a powerlifter. You need to consistently challenge your muscles in a way that stimulates growth and maintenance. And if you've never touched a barbell, that's fine. Start where you are. The research doesn't care about your gym experience. It cares about the stimulus.
2. Higher protein intake
During perimenopause, your body becomes less efficient at using protein for muscle maintenance, a phenomenon researchers call "anabolic resistance." The same amount of protein that maintained your muscle mass at 30 may not be enough at 45.
The current evidence suggests aiming for 1.0 to 1.2 grams of protein per kilogram of body weight per day, significantly higher than the general recommendation of 0.8 g/kg. For a 70 kg woman, that's 70 to 84 grams per day, distributed across meals in portions of roughly 25 to 30 grams each. Mayo Clinic Press and a 2023 narrative review in MDPI both support this range, with the caveat that the evidence quality is still developing and individual needs vary.
One critical note: a comprehensive meta-analysis found that protein supplementation improved muscle strength and mass only when combined with resistance training. Without the mechanical stimulus, higher protein alone didn't produce significant improvements. These two work as a pair. One without the other gets you halfway at best.
3. A Mediterranean-style dietary pattern
You don't need to move to Crete. You don't need a cookbook. The Mediterranean dietary pattern is less a "diet" and more a description of how people eat when they eat mostly real food: vegetables, legumes, whole grains, fish, olive oil, nuts. The reason it keeps showing up in menopause research is that it addresses multiple mechanisms at once.
A 2024 systematic review of Mediterranean diet interventions in menopausal women found beneficial effects on weight, blood pressure, triglycerides, total cholesterol, and LDL levels. The pattern is associated with reduced inflammation (which matters because of the visceral fat feedback loop we described earlier), improved insulin sensitivity, and lower risk of metabolic syndrome. A 2025 cross-sectional study further found that higher Mediterranean diet scores were associated with better menopause-specific quality of life, including reduced severity of vasomotor symptoms.
In practical terms, this means: more fibre, more healthy fats, more whole foods, less processed food, less added sugar. If your current eating looks like cereal for breakfast, a sandwich at your desk, and whatever you can manage by 7pm, even small shifts towards this pattern can help. You don't need to overhaul everything at once. The evidence describes this as a "low-risk, evidence-congruent strategy," which is researcher-speak for "this is unlikely to hurt you and reasonably likely to help."
4. HRT: the metabolic evidence your doctor may not mention
We're not going to tell you whether HRT is right for you. That depends on your health history, your risk factors, and a proper conversation with your GP or menopause specialist. But most women hear about HRT only in relation to hot flashes and night sweats. The metabolic evidence rarely comes up, and it should.
A meta-analysis of 107 randomised trials (Salpeter et al.) comparing menopausal hormone therapy to placebo found that HRT was associated with a 13% reduction in insulin resistance as measured by HOMA-IR, and an estimated 30% reduction in new-onset type 2 diabetes. More recently, a 2025 systematic review of 17 RCTs including 5,772 women, presented at The Menopause Society's Annual Meeting, confirmed that hormone therapy significantly reduces insulin resistance in non-diabetic postmenopausal women. A separate study in The Journal of Clinical Endocrinology & Metabolism found that menopausal hormone therapy was associated with reduced total and visceral adiposity.
The evidence isn't perfectly uniform. Some studies have shown that oral oestrogen can reduce glucose utilisation in certain contexts, and the type, dose, and route of HRT all matter. But the overall direction of the research is clear enough that if you're experiencing metabolic changes during perimenopause and haven't discussed HRT, the insulin resistance evidence alone makes it a conversation worth having. Bring the studies. Ask the questions. You're allowed to.
What this means for you
Your body isn't betraying you. It's responding to a fundamental hormonal shift that affects insulin signalling, fat storage, appetite regulation, and muscle maintenance all at once. Understanding the mechanism won't fix it on its own, but it changes how you approach it, and it should change how your healthcare provider approaches it too.
The "eat less, move more" advice that works for the general population can actively work against you during perimenopause. The evidence supports something different: prioritise muscle, eat enough protein, shift towards whole-food patterns, and have a real conversation with your doctor about the full range of options, including HRT.
And the next time someone tells you it's just calories in, calories out? You'll know exactly why that's not the whole story. Because you've read the research. And now, so has your GP.
This article was last updated in April 2026. We review our most-read content quarterly to ensure it reflects the latest evidence. If you believe we've misrepresented the research, please contact us. Read our full editorial standards to understand how we research and evaluate the evidence.
Sources cited in this article:
Mauvais-Jarvis, F. et al. (2021). "The Role of Estrogen in Insulin Resistance." The American Journal of Pathology. Read the study
Gremese, A. et al. (2023). "Metabolic syndrome, insulin resistance and menopause." Gynecological and Reproductive Endocrinology & Metabolism. Read the study
Pujol, T.J. et al. (2021). "Changes in abdominal subcutaneous adipose tissue phenotype following menopause." Scientific Reports. Read the study
Koothirezhi, R. & Bhargava, S. (2025). "Estrogen and Metabolism: Navigating Hormonal Transitions." PMC. Read the study
Botero, J.P. et al. (2024). "Effect of resistance training volume on body adiposity, metabolic risk, and inflammation in postmenopausal and older females." PMC. Read the study
Schmitz, K.H. et al. (2007). "Resistance Training Predicts Six-Year Body Composition Change in Postmenopausal Women." PMC. Read the study
Lim, M.T. et al. (2023). "The Impact of Protein in Post-Menopausal Women on Muscle Mass and Strength." MDPI. Read the study
Mayo Clinic Press (2024). "How much protein do you really need after menopause?" Read the article
Cena, H. et al. (2024). "Systematic review of Mediterranean diet interventions in menopausal women." AIMS Public Health. Read the study
Al-Qahtani, S.M. et al. (2025). "Association between modified Mediterranean diet score and menopause-specific quality of life." Scientific Reports. Read the study
Salpeter, S.R. et al. (2006). "Meta-analysis: Effect of hormone-replacement therapy on components of the metabolic syndrome in postmenopausal women." Read the study
The Menopause Society (2024). "New Meta-Analysis Shows That Hormone Therapy Can Significantly Reduce Insulin Resistance." Read the press release
Khosravifar, M. et al. (2025). "Hormone therapy and insulin resistance in non-diabetic postmenopausal women: a systematic review and meta-analysis." Climacteric. Read the study
Bea, J.W. et al. (2018). "Menopausal Hormone Therapy Is Associated With Reduced Total and Visceral Adiposity." The Journal of Clinical Endocrinology & Metabolism. Read the study
Batrakoulis, A. et al. (2023). "Concurrent Aerobic and Strength Training with Caloric Restriction Reduces Insulin Resistance in Obese Premenopausal Women." Medicina. Read the study
